비알코올성 지방간질환의 병발 질환

키워드

참고문헌 (49)

1. Park SH, "Prevalence and risk factors of non-alcoholic fatty liver disease among Korean adults", J Gastroenterol Hepatol, 21, pp.138~143 (2006)
2. Brea A, "Nonalcoholic fatty liver disease is associated with carotid atherosclerosis: a case-control study", Arterioscler Thromb Vasc Biol, 25, pp.1045~1050 (2005)
3. Fracanzani AL, "Carotid artery intima-media thickness in nonalcoholic fatty liver disease", Am J Med, 121, pp.72~78 (2008)
4. Targher G, "Relation of nonalcoholic hepatic steatosis to early carotid atherosclerosis in healthy men: role of visceral fat accumulation", Diabetes Care, 27, pp.2498~2500 (2004)
5. Villanova N, "Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease", Hepatology, 42, pp.473~480 (2005)
6. Davignon J, "Role of endothelial dysfunction in atherosclerosis", Circulation, 109(23 Suppl 1), pp.III27~III32 (2004)
7. Schindhelm RK, "Alanine aminotransferase as a marker of non-alcoholic fatty liver disease in relation to type 2 diabetes mellitus and cardiovascular disease", Diabetes Metab Res Rev, 22, pp.437~443 (2006)
8. Kim DH, "Non-alcoholic fatty liver disease (NAFLD) as a risk factor of coronary heart disease; relation of NAFLD to coronary artery calcification score by multi- detector computed tomography", The 43rd Annual Meeting of the European Association for the Study of the Liver Milan (2008)
9. Pitsavos C, "Risk stratification of apolipoprotein B, apolipoprotein A1, and apolipoprotein B", AI ratio on the prevalence of the metabolic syndrome: the ATTICA study, 2008, pp.59, 335~341
10. Lind L, "The apolipoprotein B", AI ratio and the metabolic syndrome independently predict risk for myocardial infarction in middle-aged men, 2006, pp.26, 406~410
11. Holme I, "Relationships between lipoprotein components and risk of myocardial infarction: age, gender and short versus longer follow-up periods in the Apolipoprotein MOrtality RISk study (AMORIS)", J Intern Med, 264, pp.30~38 (2008)
12. 이지애, "전당뇨병 환자에서 ApoB", ApoA-I Ratio와 비알코올성 지방간과의 연관성, 2010, pp.78(2), 191~197[DOI]
13. Targher G, "Increased prevalence of cardiovascular disease in Type 2 diabetic patients with nonalcoholic fatty liver disease", Diabet Med, 23, pp.403~409 (2006)
14. Yki-Järvinen H, "The fatty liver and insulin resistance", Curr Mol Med, 5, pp.287~295 (2005)
15. McCullough AJ, "Pathophysiology of nonalcoholic steatohepatitis", J Clin Gastroenterol, 40(Suppl 1), pp.S17~S29 (2006)
16. Marchesini G, "Nonalcoholic fatty liver disease and the metabolic syndrome", Curr Opin Lipidol, 16, pp.421~427 (2005)
17. Neuschwander-Teri BA, "Nonalcoholic steatohepatitis and the metabolic syndrome", Am J Med Sci, 330, pp.326~335 (2005)
18. Matsuzawa Y, "Adiponectin and metabolic syndrome", Arterioscler Thromb Vasc Biol, 24, pp.29~33 (2004)
19. Pischon T, "Plasma adiponectin levels and risk of myocardial infarction in men", JAMA, 291, pp.1730~1737 (2004)
20. Gross JL, "Diabetic nephropathy: diagnosis, prevention, and treatment", Diabetes Care, 28, pp.164~176 (2005)
21. Satchell SC, "What is the mechanism of microalbuminuria in diabetes: a role for the glomerular endothelium?", Diabetologia, 51, pp.714~725 (2008)
22. Chen J, "The metabolic syndrome and chronic kidney disease in U.S. adults", Ann Intern Med, 140, pp.167~174 (2004)
23. Lin CC, "Microalbuminuria and the metabolic syndrome and its components in the Chinese population", Eur J Clin Invest, 37, pp.783~790 (2007)
24. Targher G, "Increased risk of CKD among type 2 diabetics with nonalcoholic fatty liver disease", J Am Soc Nephrol, 19, pp.1564~1570 (2008)
25. Chang Y, "Nonalcoholic fatty liver disease predicts chronic kidney disease in nonhypertensive and nondiabetic Korean men", Metabolism, 57, pp.569~576 (2008)
26. Hwang ST, "Impact of non-alcoholic fatty liver disease on microalbuminuria in patients with prediabetes and diabetes", Intern Med J, 40, pp.437~442 (2010)
27. Wolf G, "Leptin and renal disease", Am J Kidney Dis, 39, pp.1~11 (2002)
28. Kambham N, "Obesity-related glomerulopathy: an emerging epidemic", Kidney Int, 59, pp.1498~1509 (2001)
29. Asselah T, "Steatosis in chronic hepatitis C: why does it really matter?", Gut, 55, pp.123~130 (2006)
30. Conjeevaram HS, "Race, insulin resistance and hepatic steatosis in chronic hepatitis C", Hepatology, 45, pp.80~87 (2007)
31. Adinolfi LE, "Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity", Hepatology, 33, pp.1358~1364 (2001)
32. Bugianesi E, "Fibrosis in genotype 3 chronic hepatitis C and nonalcoholic fatty liver disease: role of insulin resistance and hepatic steatosis", Hepatology, 44, pp.1648~1655 (2006)
33. Gabriel A, "Hepatocyte steatosis in HCV patients promotes fibrosis by enhancing TGF-beta liver expression", Hepatol Res, 38, pp.141~146 (2008)
34. Piche T, "The severity of liver fibrosis is associated with high leptin levels in chronic hepatitis C", J Viral Hepat, 11, pp.91~96 (2004)
35. Adams LA, "The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies", J Hepatol, 42, pp.132~138 (2005)
36. Matteoni CA, "Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity", Gastroenterology, 116, pp.1413~1419 (1999)
37. Ekstedt M, "Long-term follow-up of patients with NAFLD and elevated liver enzymes", Hepatology, 44, pp.865~873 (2006)
38. Marchesini G, "Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome", Hepatology, 37, pp.917~923 (2003)
39. Hamaguchi M, "The metabolic syndrome as a predictor of nonalcoholic fatty liver disease", Ann Intern Med, 143, pp.722~728 (2005)
40. Marchesini G, "Nonalcoholic fatty liver disease: a feature of the metabolic syndrome", Diabetes, 50, pp.1844~1850 (2001)
41. Neuschwander-Tetri BA, "Interim results of a pilot study demonstrating the early effect of the PPAR-gamma ligand rosiglitazone on insulin sensitivity, aminotransferase, hepatic steatosis and body weight in patients with non-alcoholic steatohepatitis", J Heptol, 38, pp.434~440 (2003)
42. Angulo P, "Nonalcoholic fatty liver disease", N Engl J Med, 346, pp.1221~1231 (2002)
43. Dixon JB, "Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese", Gastroenterology, 121, pp.91~100 (2001)
44. Adams LA, "Nonalcoholic fatty liver disease increase risk of death among patient with diabetes: a community- based cohort study", Am J Gastroenterol, 105, pp.1567~1573 (2010)
45. Seppälä-Lindroos A, "Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men", J Clin Endocrinol Metab, 87, pp.3023~3028 (2002)
46. Struben VM, "Nonalcoholic steatohepatitis and cryptogenic cirrhosis within kindreds", Am J Med, 108, pp.9~13 (2000)
47. Friis-Liby I, "High prevalence of metabolic complications in patients with non-alcoholic fatty liver disease", Scand J Gastroenterol, 39, pp.864~869 (2004)
48. Fan JG, "Effects of nonalcoholic fatty liver disease on the development of metabolic disorders", J Gastroenterol Hepatol, 22, pp.1086~1091 (2007)
49. Shibata M, "Nonalcoholic fatty liver disease is a risk factor for type 2 diabetes in middle-aged Japanese men", Diabetes Care, 30, pp.2940~2944 (2007)